ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/10/2026
Back to search
Official data from USPTO
GALOMIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GALOMIC
ST13
US500000097855624Class
5, 9, 40, 42
Filing
97855624
Registration
7575494
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
06/11/2026
Trademark type
Word
Nice classes
5, 9, 40, 42
Filing date
03/24/2023
Registration date
11/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
06/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
84
Owner location
LONDON, GB
Examiner
WOOD, CAROLINE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
TANGRAM THERAPEUTICS PLC
E-Therapeutics Plc
Representatives
Anna King BANNER & WITCOFF, LTD.
Technical classification
Nice Classes
Class 5Class 9Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; drug delivery agents that facilitate the delivery of pharmaceutical preparations targeting genes and silencing or inhibiting gene expression; drug delivery agents that facilitate the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs); drug delivery agents that facilitate the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs)all for targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals for use in targeting genes and blockingsilencinginhibiting gene expressionfor use in targeting mRNA and triggering its degradation; short interfering RNA-based (siRNA) medicines and pharmaceuticals for use in targeting genes and blockingsilencinginhibiting gene expressionfor use in targeting mRNA and triggering its degradation; nucleic acid-based drugs (NABDs) for use in targeting genes and blockingsilencinginhibiting gene expressionfor use in targeting mRNA and triggering its degradation; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation
Class 9
Downloadable and recorded computer software for use in the field of pharmaceuticalsmedicines and drug deliveryfor evaluatinganalysinginterpreting information contained in databases to identify new biological targets and gene-disease associations; downloadable and recorded computer software for facilitating the targeted delivery of pharmaceutical and medical preparations; downloadable and recorded computer software for facilitating the targeted delivery of pharmaceutical and medical preparations for silencing or inhibiting gene expression; downloadable and recorded computer software for facilitating the targeted delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs); downloadable and recorded computer software using artificial intelligence for machine learning for use in the field of pharmaceuticalsmedicines and drug delivery; downloadable and recorded software using artificial intelligence for machine learning for facilitating the delivery of pharmaceutical and medical preparations; downloadable and recorded software using artificial intelligence for machine learning for facilitating the delivery of pharmaceutical and medical preparations targeting genes and silencing or inhibiting gene expression; downloadable and recorded software using artificial intelligence for machine learning for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs); downloadable and recorded software using artificial intelligence for machine learning for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs)all for targeting genes and silencing or inhibiting gene expression; electronic databases for use in the field of pharmaceuticalsmedicines and drug delivery recorded on computer media; electronic databases for use in the field of gene therapy recorded on computer media; electronic databases for use in the field of gene therapythe delivery of pharmaceutical and medical preparations recorded on computer media; electronic databases for use in the field of gene therapythe delivery of pharmaceutical and medical preparations targeting and silencing or inhibiting of genes recorded on computer media; electronic databases for use in the field of gene therapythe delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs) recorded on computer media; downloadable and recorded computer platform software for use in the field of pharmaceuticalsmedicines and drug deliveryfor evaluatinganalysinginterpreting information contained in databases to identify new biological targets and gene-disease associations; downloadable and recorded computer software platforms for use in the field of pharmaceuticalsmedicines and drug deliveryfor evaluatinganalysinginterpreting information contained in databases to identify new biological targets and gene-disease associations; downloadable and recorded computer software for enabling the searching and retrieval of data relating to pharmaceuticalsmedicines and drug discovery; downloadable and recorded software for the analysis of data relating to pharmaceuticalsmedicines and drug discovery; downloadable and recorded search engine software for use in the field of pharmaceuticalsmedicines and drug discovery; downloadable and recorded search engine software for the searchingretrievalindexing and analysis of data relating to pharmaceuticalsmedicines and drug discovery
Class 40
Custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blockingsilencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blockingsilencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of informationadvice and consultancy services relating to all of the aforesaid
Class 42
Scientific research and development in the field of targeting genes and blockingsilencing or inhibiting gene expression; scientificpharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientificpharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blockingsilencing or inhibiting gene expression; scientificpharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicinesnucleic acid-based drugs (NABDs) for blocking gene expressionnucleic acid-based drugs (NABDs) for blockingsilencing or inhibiting gene expressionandpharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blockingsilencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicinesnucleic acid-based drugs (NABDs) for blockingsilencing or inhibiting gene expressionpharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to RNAi-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blockingsilencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering RNA (siRNA) medicinesnucleic acid-based drugs (NABDs) for blockingsilencing or inhibiting gene expressionpharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; designdevelopmentcreation and maintenance of computer platforms and computer software for use in the field of pharmaceuticalsmedicines and drug discovery; designdevelopmentcreation and maintenance of computer platforms and computer software enabling the searching and retrieval of data relating to pharmaceuticalsmedicines and drug discovery; designdevelopmentcreation and maintenance of computer platforms and computer software for the analysis of data relating to pharmaceuticalsmedicines and drug discovery; design of and providing temporary use of online non-downloadable search engine software for use in the field of pharmaceuticalsmedicines and drug discovery; design of and providing temporary use of online non-downloadable search engine software for the searchingretrievalindexing and analysis of data relating to pharmaceuticalsmedicines and drug discovery; Platform as a Service (PaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for modelling genetic sequences and gene-disease associationsfor identifying and ranking potential gene targetsfor generating pharmaceutical and medical preparations all for use in the fields of pharmaceuticalsmedicines and drug discovery; Platform as a Service (PaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for modelling genetic sequences and gene-disease associationsfor identifying and ranking potential gene targetsfor generating RNAi-based medicines and pharmaceuticalsshort interfering RNA (siRNA) medicinesnucleic acid-based drugs (NABDs) for blockingsilencing or inhibiting gene expressionpharmaceutical and medical preparations for use in targeting mRNA and triggering its degradationall for use in the fields of pharmaceuticalsmedicinesdrug discovery; design and development of computer-simulated models for use in the field of pharmaceuticalsmedicines and drug discovery; providing temporary use of online non-downloadable computer software for evaluatinganalysinginterpreting information contained in databases to identify new biological targets and gene-disease associationsall for use in the field of pharmaceuticalsmedicines and drug delivery; providing temporary use of online non-downloadable computer software for facilitating the targeted delivery of pharmaceutical and medical preparationsall for use in the field of pharmaceuticalsmedicines and drug delivery; providing temporary use of online non-downloadable computer software for facilitating the targeted delivery of pharmaceutical and medical preparations for silencing or inhibiting gene expressionall for use in the field of pharmaceuticalsmedicines and drug delivery; providing temporary use of online non-downloadable computer software for facilitating the targeted delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs)all for use in the field of pharmaceuticalsmedicines and drug delivery; providing temporary use of online non-downloadable computer for machine learning for use in the field of pharmaceuticalsmedicines and drug delivery; providing temporary use of online non-downloadable computer software using artificial intelligence for machine learning for facilitating the delivery of pharmaceutical and medical preparationsall for use in the field of pharmaceuticalsmedicines and drug delivery; providing temporary use of online non-downloadable computer software using artificial intelligence for machine learning for facilitating the delivery of pharmaceutical and medical preparations targeting genes and silencing or inhibiting gene expressionall for use in the field of pharmaceuticalsmedicines and drug delivery; providing temporary use of online non-downloadable computer software using artificial intelligence for machine learning for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs)all for use in the field of pharmaceuticalsmedicines and drug delivery; providing temporary use of online non-downloadable computer software using artificial intelligence for machine learning for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticalsnucleic acid-based drugs (NABDs)all for targeting genes and silencing or inhibiting gene expressionall for use in the field of pharmaceuticalsmedicines and drug delivery; Software as a Service (SaaS) services featuring software using artificial intelligence and machine learning software for modelling genetic sequences and gene-disease associationsfor identifying and ranking potential gene targetsfor generating pharmaceutical and medical preparations databases all in the field of pharmaceuticalsmedicines and drug discovery; Software as a Service (SaaS) services featuring software using artificial intelligence and machine learning for modelling genetic sequences and gene-disease associationsfor identifying and ranking potential gene targetsfor generating RNAi-based medicines and pharmaceuticalsnucleic acid-based drugs (NABDs) for blockingsilencing or inhibiting gene expressionpharmaceutical and medical preparations for use in targeting mRNA and triggering its degradationall for use in the fields of pharmaceuticalsmedicines and drug discovery; provision of informationadvice and consultancy services relating to all of the aforesaid
Publications
History of USPTO decisions and trademark events.
29 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
11/05/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/04/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/30/2024
EX1G
SOU EXTENSION 1 GRANTED
04/29/2024
EXT1
SOU EXTENSION 1 FILED
04/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/29/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2023
PUBO
PUBLISHED FOR OPPOSITION
10/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/31/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/29/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/29/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/29/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/29/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/24/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/27/2023
GNRT
NON-FINAL ACTION E-MAILED
04/27/2023
CNRT
NON-FINAL ACTION WRITTEN
04/27/2023
DOCK
ASSIGNED TO EXAMINER
04/25/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2023
NWAP
NEW APPLICATION ENTERED
03/28/2023
Continuous trademark protection
Get notified about every new filing that threatens GALOMIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.